66 related articles for article (PubMed ID: 1338173)
1. Effectiveness of chemical agents in removing platinum from DNA isolated from cisplatin-treated HL-60 cells.
Oliński R; Briggs RC; Basinger M; Jones MM
Acta Biochim Pol; 1992; 39(4):327-34. PubMed ID: 1338173
[TBL] [Abstract][Full Text] [Related]
2. The prevention of cisplatin-induced renal dysfunction by hydroxyl-containing dithiocarbamates.
Reznik LV; Myazina EM; Shakchmatova EI; Gambaryan SP; Brovtsyn VK; Natochin YV; Jones MM
Br J Cancer; 1991 Feb; 63(2):234-6. PubMed ID: 1847647
[TBL] [Abstract][Full Text] [Related]
3. Effect of diethyldithiocarbamate on cis-diamminedichloroplatinum(II)-induced cytotoxicity, DNA cross-linking, and gamma-glutamyl transpeptidase inhibition.
Bodenner DL; Dedon PC; Keng PC; Borch RF
Cancer Res; 1986 Jun; 46(6):2745-50. PubMed ID: 2870800
[TBL] [Abstract][Full Text] [Related]
4. Comparative effects of diethyldithiocarbamate and N-benzyl-D-glucamine dithiocarbamate on cis-diamminedichloroplatinum-induced toxicity in kidney and gastrointestinal tract in rats.
Hidaka S; Funakoshi T; Shimada H; Tsuruoka M; Kojima S
J Appl Toxicol; 1995; 15(4):267-73. PubMed ID: 7594195
[TBL] [Abstract][Full Text] [Related]
5. Prevention of renal toxicity of cis-diamminedichloroplatinum by dithiocarbamates in rats.
Shimada H; Sugimachi N; Funakoshi T; Kojima S
Toxicol Lett; 1993 Feb; 66(2):193-8. PubMed ID: 8430439
[TBL] [Abstract][Full Text] [Related]
6. Protective effects of dithiocarbamates against renal toxicity of cis-diamminedichloroplatinum in rats.
Hidaka S; Tsuruoka M; Funakoshi T; Shimada H; Kiyozumi M; Kojima S
Ren Fail; 1994; 16(3):337-49. PubMed ID: 8059017
[TBL] [Abstract][Full Text] [Related]
7. Antipseudomonal effects of selected dithiocarbamates alone and in combination with gentamicin or aztreonam.
Walker EM; Hardin HF; Gale GR; Reifsteck ME; Cannon DJ; Jones MM
Res Commun Chem Pathol Pharmacol; 1989 Jan; 63(1):101-17. PubMed ID: 2536949
[TBL] [Abstract][Full Text] [Related]
8. Effects of diethyldithiocarbamate and nine other nucleophiles on the intersubunit protein cross-linking and inactivation of purified human alpha 2-macroglobulin by cis-diamminedichloroplatinum(II).
Gonias SL; Oakley AC; Walther PJ; Pizzo SV
Cancer Res; 1984 Dec; 44(12 Pt 1):5764-70. PubMed ID: 6209003
[TBL] [Abstract][Full Text] [Related]
9. Enhanced replicative bypass of platinum-DNA adducts in cisplatin-resistant human ovarian carcinoma cell lines.
Mamenta EL; Poma EE; Kaufmann WK; Delmastro DA; Grady HL; Chaney SG
Cancer Res; 1994 Jul; 54(13):3500-5. PubMed ID: 8012973
[TBL] [Abstract][Full Text] [Related]
10. Prevention of cisplatin-induced toxicity by selected dithiocarbamates.
Walker EM; Fazekas-May MA; Heard KW; Yee S; Montague D; Jones MM
Ann Clin Lab Sci; 1994; 24(2):121-33. PubMed ID: 8203821
[TBL] [Abstract][Full Text] [Related]
11. Mechanism-related circumvention of acquired cis-diamminedichloroplatinum(II) resistance using two pairs of human ovarian carcinoma cell lines by ammine/amine platinum(IV) dicarboxylates.
Kelland LR; Mistry P; Abel G; Loh SY; O'Neill CF; Murrer BA; Harrap KR
Cancer Res; 1992 Jul; 52(14):3857-64. PubMed ID: 1617660
[TBL] [Abstract][Full Text] [Related]
12. Appearance of electron spin resonance signals in the interaction of dithiocarbamate-Fe(II) with nitrogen dioxide and nitrite.
Hiramoto K; Tomiyama S; Kikugawa K
Free Radic Res; 1997 Nov; 27(5):505-9. PubMed ID: 9518067
[TBL] [Abstract][Full Text] [Related]
13. Control of some aspects of cis-platinum nephrotoxicity.
Jones MM; Basinger MA; Craft WD; Domingo JL; Llobet JM
Arch Toxicol; 1986 Oct; 59(3):167-71. PubMed ID: 3028320
[TBL] [Abstract][Full Text] [Related]
14. Increased removal of DNA-bound platinum in a human ovarian cancer cell line resistant to cis-diamminedichloroplatinum(II).
Masuda H; Tanaka T; Matsuda H; Kusaba I
Cancer Res; 1990 Mar; 50(6):1863-6. PubMed ID: 2306738
[TBL] [Abstract][Full Text] [Related]
15. Kinetics and mechanism of the 1-beta-D-arabinofuranosylcytosine-induced potentiation of cis-diamminedichloroplatinum(II) cytotoxicity.
Vadi H; Drewinko B
Cancer Res; 1986 Mar; 46(3):1105-9. PubMed ID: 3080232
[TBL] [Abstract][Full Text] [Related]
16. Effects of dithiocarbamates on cadmium distribution and excretion in chronically exposed rats.
Cikrt M; Lepsi P; Horáková L; Bláha K; Bittnerová D; Jones MM
J Toxicol Environ Health; 1986; 17(4):419-27. PubMed ID: 3959121
[TBL] [Abstract][Full Text] [Related]
17. Dependence on chelating agent properties of nephrotoxicity and testicular damage in male mice during cadmium decorporation.
Jones SG; Holscher MA; Basinger MA; Jones MM
Toxicology; 1988 Dec; 53(1):135-46. PubMed ID: 3201473
[TBL] [Abstract][Full Text] [Related]
18. cis-diamminedichloroplatinum(II) cross-linking of the human myeloid cell nuclear differentiation antigen to DNA in HL-60 cells following 1,25-dihydroxy vitamin D3-induced monocyte differentiation.
Gaczynski M; Briggs JA; Wedrychowski A; Olinski R; Uskokovic M; Lian JB; Stein GS; Briggs RC
Cancer Res; 1990 Feb; 50(4):1183-8. PubMed ID: 2297767
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the effectiveness of dithiocarbamates on the excretion and distribution of cadmium in mice.
Shimada H; Funakoshi T; Kiyozumi M; Kojima S
Res Commun Chem Pathol Pharmacol; 1991 Aug; 73(2):249-52. PubMed ID: 1784839
[TBL] [Abstract][Full Text] [Related]
20. Systemic and tumor disposition of platinum after administration of cisplatin or STEALTH liposomal-cisplatin formulations (SPI-077 and SPI-077 B103) in a preclinical tumor model of melanoma.
Zamboni WC; Gervais AC; Egorin MJ; Schellens JH; Zuhowski EG; Pluim D; Joseph E; Hamburger DR; Working PK; Colbern G; Tonda ME; Potter DM; Eiseman JL
Cancer Chemother Pharmacol; 2004 Apr; 53(4):329-36. PubMed ID: 14673619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
